A vaccine has been shown for the first time to protect against life-threatening staph infections, a major hazard among hospital patients, researchers said today.
The genetically engineered vaccine was tested first in kidney dialysis patients, and it cut their risk of staph blood poisoning in half for nearly a year.
“I am quite encouraged by this. It could be a major breakthrough in this area,” said Dr. Steve Black of the Kaiser Permanente Vaccine Study Center in Oakland, Calif.
Black presented the results in a last-minute addition to the program of the annual infectious disease meeting of the American Society for Microbiology.
The vaccine, called StaphVAX, was created at the National Institutes of Health and is being developed by Nabi Corp. of Boca Raton, Fla., which financed the latest study.
Staphylococcus aureus is a common and ordinarily harmless inhabitant of the human nasal tract. It can live for days outside the body on almost any surface and spreads widely in hospitals, where it can cause serious infections among those who are already sick, especially if they have weak immune defenses.
Infection Sometimes Fatal
Staph can be deadly if it invades the bloodstream. It can lead to pneumonia, encephalitis, liver abscesses and other problems.
Staph infections are relatively common among people who use needles frequently, such as diabetics and dialysis patients, elderly people in nursing homes and those who are hospitalized for surgery and a variety of other conditions.
Doctors conducted the first large test of StaphVAX in dialysis patients because typically between 1 percent and 3 percent of them get bloodstream staph infections each year.
Robert B. Naso, Nabi’s research director, said the company will seek approval soon from the U.S. Food and Drug Administration to produce and sell the vaccine.
The study enrolled 1,804 patients at 90 dialysis centers in California. Half got the vaccine, while the rest took dummy shots.
The vaccine appeared to quickly lower the risk of staph. After 10 months, there were 11 serious infections among those getting the vaccine, compared with 26 in the unprotected group, a 57 percent reduction.
The vaccine triggers the body to make fresh antibodies against staph. After one year, the patients’ antibody levels dropped, and their protection against staph began to fade.
Dr. Julie Gerberding, head of hospital infections at the U.S. Centers for Disease Control and Prevention, noted that staph is an especially difficult problem for dialysis patients.
A Growing Immunity to Antibiotics
“If you can get this much protection in them, it might work even better in other patients,” she said.
Staph infections are of particular concern because the bacteria is growing immune to the antibiotics commonly used to treat it. Half of all staph that circulates in hospitals is resistant to methicillin, the standard drug. Now it is developing resistance to vancomycin, the main backup drug.
Black said the new vaccine could be given to build up staph resistance in surgery patients, who are prone to the infection. It might also be used in nursing homes, among diabetes patients and in people who are hospitalized for a variety of problems.
The Latest on: Staph Infections
via Google News
The Latest on: Staph Infections
- Dartmouth researcher close to new MRSA busting drugon October 12, 2020 at 3:45 pm
When Karl Griswold’s daughter was a year old she got a skin infection that turned out to be MRSA, or Methicillin-resistant Staphylococcus aureus, a potentially deadly or disfiguring bacteria.Griswold ...
- Healthcare Acquired Infection Market Research Trends Analysis by 2020 to 2025on October 5, 2020 at 12:27 am
The Healthcare Acquired Infection Market is expected to exceed more than US$ 25.2 Billion by 2024 at a CAGR of 6.1% in the given forecast period. FYI, You will get latest updated report as per the ...
- World MRSA Day - the Ongoing Global MRSA Epidemicon October 2, 2020 at 5:31 am
MRSA must immediately become a top political priority, people are dying and suffering needlessly," states Jeanine Thomas, founder of World MRSA Day and ...
- Researchers develop single-use treatment for ear infections that doesn't need refrigerationon September 30, 2020 at 7:23 pm
Outer ear infections, which affect millions of people each year, are typically caused by the bacteria Pseudomonas aeruginosa or Staphylococcus aureus.
- A single-application treatment for ear infections that doesn't need refrigerationon September 30, 2020 at 9:52 am
Outer ear infections, which affect millions of people each year, are typically caused by the bacteria Pseudomonas aeruginosa or Staphylococcus aureus. Repeatedly administering antibiotic drops, the ...
- Richmond midfielder Dion Prestia reveals how he recovered from golden staph infection to return for finalson September 27, 2020 at 11:32 pm
By Round 4’s loss to St Kilda, as Richmond slumped to a single victory from four games, Jack Riewoldt was officially categorised as shot.
- Fact check: Staph infections are common and aren't caused by face maskson September 18, 2020 at 5:23 pm
The claim: Face masks cause staph infections. Since the Centers for Disease Control and Prevention recommended the use of face masks in public in April, misinformation about the consequences of ...
- New document discusses how to prevent staphylococcus aureus infections in critically ill infantson September 14, 2020 at 11:48 pm
Neonatal intensive care units (NICU) should balance the prevention of Staphylococcus aureus infections in critically ill infants with the need for skin-to-skin contact with parents and siblings ...
- Guidance balances staph infection prevention in critically ill infants with family contacton September 14, 2020 at 9:54 am
"Infants remain at risk for Staph infections, yet there are effective strategies to decrease transmission that can easily be applied within the NICU without sacrificing the vital benefits these ...
- Guidance balances staph infection prevention in critically ill infants with family contacton September 14, 2020 at 9:09 am
NEW YORK (September 14, 2020) -- Neonatal intensive care units (NICU) should balance prevention of Staphylococcus aureus infections in critically ill infants with the need for skin-to-skin contact ...
via Bing News